Alex Brewer: All Documents

Division Vote (Commons)
21 Apr 2026 - English Devolution and Community Empowerment Bill - View Vote Context
Alex Brewer (LD) voted No - in line with the party majority and against the House
One of 56 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes
Vote Tally: Ayes - 287 Noes - 150

Division Vote (Commons)
21 Apr 2026 - English Devolution and Community Empowerment Bill - View Vote Context
Alex Brewer (LD) voted No - in line with the party majority and against the House
One of 55 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes
Vote Tally: Ayes - 288 Noes - 147

Division Vote (Commons)
21 Apr 2026 - English Devolution and Community Empowerment Bill - View Vote Context
Alex Brewer (LD) voted No - in line with the party majority and against the House
One of 55 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes
Vote Tally: Ayes - 298 Noes - 152

Division Vote (Commons)
21 Apr 2026 - English Devolution and Community Empowerment Bill - View Vote Context
Alex Brewer (LD) voted No - in line with the party majority and against the House
One of 55 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes
Vote Tally: Ayes - 297 Noes - 147

Division Vote (Commons)
21 Apr 2026 - English Devolution and Community Empowerment Bill - View Vote Context
Alex Brewer (LD) voted No - in line with the party majority and against the House
One of 55 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes
Vote Tally: Ayes - 293 Noes - 155

Written Question

Cerebrospinal Fluid Shunts: Magnets

Tuesday 21st April 2026

Asked by: Alex Brewer (Liberal Democrat - North East Hampshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of high strength retail sold magnets, including those imported outside of the UK and EU regulatory frameworks, on the safety and functioning of cerebrospinal fluid shunts.

Answered by Zubir Ahmed

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines, medical devices, and blood components for transfusions on the market in the United Kingdom are safe, effective, and manufactured to the highest standards of quality. The Medical Devices Regulations 2002 (MDR 2002) established the statutory framework that medical devices, including cerebrospinal fluid shunts, must meet in order to comply with these standards.

The manufacturer is legally responsible for obtaining the necessary certification, registering their medical devices with the MHRA, the UK Competent Authority, and undertaking post-market surveillance. Higher risk medical devices are assessed and approved by Approved Bodies, for UKCA marking, or Notified Bodies, for CE marking. Manufacturers consider anticipated conditions within intended environments of use, such as those with high magnet fields, for instance magnetic resonance imaging, when designing and manufacturing devices. As part of meeting the requirements of the MDR 2002, manufacturers must provide instructions for use, including implant cards and implant information, any special operating instructions, any warnings and/or precautions to take, and precautions to be taken as regards exposure, in reasonably foreseeable environmental conditions, to magnetic fields.

The MHRA has published guidance on how electromagnetic interference can affect several types of medical devices that have electrical or electronic systems and mitigation steps. This guidance is available at the following link:

https://www.gov.uk/government/publications/electromagnetic-interference-sources/electromagnetic-interference-sources

Division Vote (Commons)
20 Apr 2026 - Crime and Policing Bill - View Vote Context
Alex Brewer (LD) voted No - in line with the party majority and against the House
One of 53 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes
Vote Tally: Ayes - 294 Noes - 61